Pre-lease free cash flow collapsed 70.9% as capex outpaced operating cash

Comparable note: HY22 was selected on an inferred basis rather than an exact same-period filing match.

What changed

Revenue from continuing operations rose 10.6% to $274.2m, but reported profit moved the other way: PBT fell 20.8% to $217.3m and IFRS NPAT fell 31.1% to $194.0m. The company's preferred underlying profit measure went the opposite direction again, up 44.8% to $138.8m, with management citing strong resale margins. Operating cash flow fell 19.1% to $243.7m, while purchases of property, plant and equipment rose to $191.9m from $123.1m, cutting pre-lease free cash flow to $51.8m from $178.0m. Gross borrowings climbed to $3b from $2.5b, lifting net debt to roughly $3b. The interim dividend was held at 8.8 cps and a dividend reinvestment plan was introduced. New Zealand still drives the top line at 87.9% of revenue (down from 91.5%), while Australia's revenue share lifted to 12.2% with a disclosed segment profit jump to $65.3m from $3.0m.

What matters

• Three different earnings stories. Underlying profit (+44.8%), PBT (-20.8%) and NPAT (-31.1%) all point in different directions. PBT is the cleaner read on the IFRS result: a $23.3m tax expense this period (effective rate -10.7% on a positive PBT) versus a $6.9m tax benefit prior widened the gap to NPAT by 10.2pp. Investors need to lean on PBT or the underlying measure rather than headline NPAT growth.
• Cash quality has clearly deteriorated. Capex rose to roughly 70.0% of revenue from 49.7%, and pre-lease FCF fell about 70.9%. The interim dividend now consumes about 85.0% of pre-lease FCF versus 24.8% a year ago — coverage that helps explain why a DRP has been introduced.
• Leverage is moving the wrong way. Net debt rose roughly $565m to about $3b while equity grew only $594.3m on a 22.2% larger asset base. With EBITDA not disclosed, leverage ratios cannot be computed, but the direction is unambiguously weakening.

Expectations

No forward work, settlement pipeline or quantitative guidance was disclosed in the supplied extract, and there are no stated targets to test against. Annualised HY23 revenue of $548.5m sits about 8.9% above FY22 revenue of $503.8m, so the top-line run-rate is ahead of last year. However, FY22 was heavily second-half weighted on NPAT (HY22 was only 40.6% of full-year NPAT), so seasonality in IFRS profit cannot be inferred from this half alone given the fair-value-driven nature of that line in retirement village reporting.

Quality of result

The 10.6% revenue gain and the 44.8% lift in underlying profit on resale margins look operationally driven, and the Australian segment's improved profit contribution is a genuine mix shift, even if the base is small. Beyond that, the quality of the result is mixed. Trade and other receivables jumped to $791.9m from $509.4m — receivable days using half-year revenue as the denominator stretched to roughly 526 from 374, although in a retirement village model this line includes occupancy advance receivables and is not a pure trade-debtor read. Either way, the cash conversion deterioration is real: OCF fell while reported revenue rose, and the step-up in capex absorbed most of what was generated. The IFRS result remains heavily exposed to fair-value movements that do not flow through cash, and the supplied excerpt does not include a full underlying-to-IFRS reconciliation.

Unresolved

• What drove receivables up $282.4m, and how much is settlement-timing on new village stock versus a structural lengthening?
• What is the planned capex trajectory into 2H, given pre-lease FCF only just covered the dividend at the announced rate?
• How is Australia's segment profit composed — is the step-up to $65.3m operating margin or fair-value-driven?
• What is the expected DRP take-up assumption, and does management see it as a temporary measure or a recurring source of equity funding?
• No EBITDA, no net-debt-to-EBITDA, no NTA per share and no forward work pipeline are disclosed in the supplied extract, so this briefing cannot assess leverage on a multiple basis, NTA-based valuation, or sales-pipeline support for the second half.

Key metrics

Segment breakdown

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.